APASL Oncology 2022 Takamatsu will be held!

Scientific program : http://www.apaslstc-takamatsu2022.org/docs/program/APASL_Oncology2022_20220720-1100.pdf

List of distinguished guest speakers: http://www.apaslstc-takamatsu2022.org/docs/Invited/Invited_Guest_APASL_Oncology_2022_Takamatsu_220718.pdf

Please check it out!!

What's New

2025/10/30
APASL STC 2025 Qingdao will be held on Nov 28-30, 2025!!

Conference date of APASL STC 2025 Qingdao has been changed to November 28-30, 2025 !! We are waiting for your … [Read more]
2025/10/28
Please check out our Guideline page !!

Please check out our Guideline page from the following URL !! Guidelines
2025/10/24
The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes.

The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes. This … [Read more]
2025/10/23
This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities.

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), … [Read more]
2025/10/21
Do the therapeutic vaccines hold hope for the treatment of hepatitis B ?

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), … [Read more]

What's New